Avanos Medical
AVNS
AVNS was delisted on the 24th of July, 2026.
Fund managers haven’t disclosed any holdings of AVNS yet.
AVNS Hedge Fund Activity: Q1 2026 in Review
257 of the 8,133 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q1 2026, worth a combined $631M — up 24% from $510M a quarter earlier.
Sellers outnumbered buyers: 42 funds closed out of AVNS and 30 opened new positions — a net loss of 12 holders — while 72 trimmed existing stakes and 71 added.
The largest buyer was Boone Capital Management, opening a new position worth an estimated $16M. The largest seller was Armistice Capital, cutting an estimated $16.2M.
- 257 institutional investors held Avanos Medical (AVNS) as of Q1 2026, down from 274 in Q4 2025.
- Funds reported $631M of Avanos Medical stock for Q1 2026, up 24% quarter-over-quarter.
- 30 funds opened new Avanos Medical positions in Q1 2026 and 42 closed out, a net change of -12 holders.
- The largest Avanos Medical buyer in Q1 2026 was Boone Capital Management, an estimated $16M added.
- The largest Avanos Medical seller in Q1 2026 was Armistice Capital, an estimated $16.2M sold.
Based on aggregated 13F filings for Q1 2026.